the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Empower General Assembly instead of restructuring UNSC, says analyst

PETALING JAYA: Reforming the United Nations Security Council (UNSC) is almost impossible without the consent of its five permanent members who wield veto powers, making it more realistic to strengthen the authority of the UN General Assembly (Unga), said geopolitical analyst Dr Azmi Hassan.

He said the Gaza conflict and other crises have exposed paralysis within the UNSC, with the United States, Russia, China, the United Kingdom and France routinely blocking resolutions that clash with their interests.

“The problem with restructuring the Security Council is that it requires agreement from the very same five nations that hold veto powers.

“This is almost impossible. As a result, the UNSC has failed repeatedly to act effectively on urgent matters such as Palestine and Ukraine,” he told theSun.

Azmi said the 10 rotating non-permanent seats add little weight since they cannot override vetoes, creating an imbalance that undermines the credibility of the council.

He said instead of pursuing an “unrealistic” reform of the UNSC, the General Assembly, which represents all 193 member states equally, should be empowered.

“If Unga resolutions are granted binding power similar to those of the Security Council, the UN could function more effectively.

“Unlike the UNSC, the General Assembly has no veto powers, meaning every nation has an equal voice.”

Azmi added that empowering the Unga would restore credibility by ensuring that decisions reflect the collective will of nations.

He was commenting on Foreign Minister Datuk Seri Mohamad Hasan’s address at the Unga, in which Malaysia called for the abolition or restriction of the Security Council veto.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings